Filing Details

Accession Number:
0001209191-18-047230
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-16 21:24:08
Reporting Period:
2018-08-14
Accepted Time:
2018-08-16 21:24:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1636651 Ovid Therapeutics Inc. OVID Pharmaceutical Preparations (2834) 465270895
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654055 Karen Bernstein C/o Ovid Therapeutics Inc.
1460 Broadway, Suite 15044
New York NY 10036
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-14 10,000 $6.23 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.005 to $6.5467 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.